Activation of NF-κB Signaling Pathway in Peripheral Blood Mononuclear Cells of Patients with Systemic Lupus Erythematosus

许韩师,叶任高,孙林,杨琼琼,曾丽霞,李志坚,李幼姬

DOI: https://doi.org/10.3760/j.issn:0412-4030.2001.01.004

2001-01-01

Abstract:Objective To detect the activation of NF-kB signaling pathway in peripheral blood mononuclear cells(PBMCs) of patients with systemic lupus erythematosus(SLE) and investigate its clinical significance. Methods Activation of NF-kB was detected by electrophoretic mobility shift assay(EMSA), the expression of IkBα protein and its phosphorylated products were detected by Western blot. Anti -dsDNA antibody, IgG and IgM in supernatant of PBMC culture were tested by ELISA. Results (1)Elevated activation of NF-kB in PBMC of SLE patients was found when compared with the controls(P<0.05), and activation of NF-kB in active SLE group was higher than that of inactive SLE group(P<0.05). (2) The expression of IkBα in SLE group was lower than that of the control group(P<0.05), and IkBαin active SLE group was lower than that of inactive SLE group(P<0.05). (3)IkBα phosphorylated product in SLE group was higher than that in the control group, and the product in the active SLE group was increased compared with the inactive SLE group. (4)The activation of NF-kB and IkBα phosphorylated product had a positive correlation with the titer of anti-dsDNA antibody, IgG in the supernatant of PBMC culture and SLEDAI, respectively. Conclusions There are abnormal activation of NF-kB signaling pathway in SLE. Detection of activation of NF-kB signaling pathway in PBMC may be used as a predicator of SLE disease activity.